Literature DB >> 18177956

Radial augmentation index associated with increase in B-type natriuretic peptide in patients with hypertension.

Satoru Sakuragi1, Takeshi Maruo, Manabu Taniguchi, Satoshi Nagase, Kazufumi Nakamura, Kengo Fukushima Kusano, Tohru Ohe.   

Abstract

Brain natriuretic peptide (BNP) level has been used as a marker of left ventricular (LV) systolic dysfunction (LVSD), even though some patients with atherosclerosis have a high BNP level irrespective of LV function. In this study, we investigate whether augmentation index (AI), which is an index of wave reflection, is involved in increasing BNP level in hypertensive patients without LVSD. Sixty treated hypertensive patients were enrolled in this study. Radial AI (r-AI) was measured in all patients. The patients were classified into tertiles on the basis of r-AI to identify the characteristics of the patients with a high r-AI. BNP level was significantly higher in the patients classified into the highest tertile of r-AI. In echocardiography, e', which is index of left ventricular (LV) diastolic function, decreased and LV mass index (LVMI) increased gradually with r-AI, whereas there was no difference in LV ejection fraction (LVEF). r-AI significantly correlated with LVMI (r=0.35, p<0.01) and e' (r=-0.30, p<0.05). In univariate analysis, age, heart rate, r-AI, LVEF, e' and LVMI were significantly correlated with BNP level, whereas multivariate analysis demonstrated that only r-AI and LVEF correlated with BNP level. In conclusion, an increase in r-AI was significantly associated with an increase in BNP level in hypertensive patients without LVSD. LV hypertrophy and diastolic dysfunction associated with increase in r-AI may be involved in increase in BNP level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18177956     DOI: 10.1016/j.ijcard.2007.08.129

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

Review 1.  Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 2): Clinical and Therapeutic Considerations.

Authors:  Julio A Chirinos
Journal:  J Cardiovasc Transl Res       Date:  2017-04-11       Impact factor: 4.132

2.  Differential Effects in Cardiovascular Markers between High-Dose Angiotensin II Receptor Blocker Monotherapy and Combination Therapy of ARB with Calcium Channel Blocker in Hypertension (DEAR Trial).

Authors:  Kenichiro Kinouchi; Atsuhiro Ichihara; Kanako Bokuda; Hideaki Kurosawa; Hiroshi Itoh
Journal:  Int J Hypertens       Date:  2011-06-27       Impact factor: 2.420

3.  A new tonometric device for radial augmentation index and subendocardial viability ratio: potential use in health screening.

Authors:  Jing-Zhi Wang; Yong-Liang Zhang; Fu-Song Hu; Zi-Jun He; Xian-Jun Yang; Zu-Chang Ma; Yi-Ning Sun
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-09-09       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.